Skip to main content
. Author manuscript; available in PMC: 2021 Sep 25.
Published in final edited form as: Int J Pharm. 2020 Jul 11;587:119623. doi: 10.1016/j.ijpharm.2020.119623

Figure 4.

Figure 4.

Percentage of stable TAFaq released in vitro in sink solution from surrogate implants loaded with either TAFfb or TAFfs. Data are presented as meanĀ±STD (n=5 replicates per group until day 44, n=4 thereafter).